OUR STORY

Carmen's Biopharma is on a remarkable journey to redefine diabetes treatment using cannabinoids.

Inspired by the therapy that significantly helped Carmen, the founder's grandmother, we aim to make a real difference in the lives of diabetes patients. Our story is a testament to our dedication and passion for advancing medical solutions.

OUR TEAM

World-Class Leadership

Scientific, clinical, and financial expertise

Scientific Founder

Prof. Joseph Tam

Hebrew University; metabolic endocannabinoid expert; inventor of core CBD/CBG patent

Scientific Advisor

Dr. Ethan Russo

World-renowned cannabinoid scientist and clinician.

Clinical Advisor

Dr. Lanzoni

Diabetes Research Institute,

University of Miami; leading

diabetes/metabolic clinician.

Clinical Operations

Precefi

Highly experienced Clinical Research team that has a Track records in bringing biotech startups to successful exits in +2B

CEO, Founder

Juan Romero

Experienced biopharma entrepreneur with ~$12M prior cannabinoid revenue

Investor

Michael Douglas

Academy Award-winning actor and producer; long-time advocate for health and wellness initiatives. Mr. Douglas is a very successful investor in the Pharmaceutical Industry. He got involved with Carmens because he believes in CBDs potential.

Investor

Rich Panico

Mr. Panico is an experienced biotech executive and co-founder/CEO of Symbio, which he grew into a leading U.S. and European CRO, supporting 70+ FDA and EMA approvals and a successful M&A exit.

Investor

John Lynch

Strategic investor supporting Carmen’s Biopharma mission.

Scaled ventures to

$1B+ with bold strategies.

Legal Counsel

Dale Hunt

Patent attorney with deep expertise in life sciences IP, patent strategy, and global commercialization, and previously was a partner at multiple national law firms.

Legal & Compliance

Hogal Lovells

Hogan Lovells is a leading global law firm with deep expertise in life sciences, providing legal and regulatory counsel across drug development, FDA strategy, IP, and complex cross-border matters.

OUR MISSION

Empowering Patients, Inspiring Change.

At Carmen's Biopharma, we are committed to redefining the way diabetes is treated. Our mission is to empower patients with innovative cannabinoid therapies that offer hope and healing. We believe in providing personalized care and leading the way in diabetes management.

medium-shot-diabetic-woman-checking-her-glucose-level_edited.jpg

OUR PROGRESS SO FAR

2018

FOUNDED

Carmens Biopharma was founded with a vision to revolutionize diabetes treatment through cannabinoid research and drug development.

2020

INITIATION OF DRUG DEVELOPMENT PLAN

We embarked on our drug development plan, marking a significant milestone in our journey to bring advanced cannabinoid therapies to patients in need.

OUR STORY

OUR TEAM

OUR MISSION

OUR PROGRESS SO FAR

NEWS & UPDATES

Carmen's Biopharma in the Spotlight

Quick Links

About

Contact Us

SUBSCRIBE